Adaptive, Iterative, Long-Term Personalized Therapy Management in a Case of Stage IV Refractory NSCLC
In this paper we report long-term therapy management based on iterative de novo molecular and cellular analysis in a case of metastatic non-small cell lung cancer (NSCLC), with prior history of treated colorectal cancer. In the described case temporal tumor evolution, emergent therapy resistance and...
Main Authors: | Anantbhushan Ranade, Darshana Patil, Amit Bhatt, Rucha Dhasare, Vineet Datta, Rajan Datar, Dadasaheb Akolkar |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-07-01
|
Series: | Journal of Personalized Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4426/9/3/34 |
Similar Items
-
Multi-analyte liquid biopsies for molecular pathway guided personalized treatment selection in advanced refractory cancers: A clinical utility pilot study
by: Darshana Patil, et al.
Published: (2022-12-01) -
Precision Surgery in NSCLC
by: Giorgio Cannone, et al.
Published: (2023-03-01) -
The diagnostic significance of blood-derived circRNAs in NSCLC: Systematic review and meta-analysis
by: Weijie Yu, et al.
Published: (2022-10-01) -
Liquid Biopsy in NSCLC: An Investigation with Multiple Clinical Implications
by: Elisa Bertoli, et al.
Published: (2023-06-01) -
Landscape of Genomic Alterations and PD-L1 Expression in Early-Stage Non-Small-Cell Lung Cancer (NSCLC)—A Single Center, Retrospective Observational Study
by: Susann Stephan-Falkenau, et al.
Published: (2022-10-01)